Spikevax XFG (50 Microgramm) Injektionsdispersion in einer Fertigspritze

7680708470010 CH-70847 Fertigspritze

No image available

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Fertigspritze
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
11/08/2026
Patient information leaflet
Français
11/08/2026
Patient information leaflet
Italien
11/08/2026
Summary of Product Characteristics
Allemand
11/08/2026
Summary of Product Characteristics
Français
11/08/2026
Summary of Product Characteristics
Italien
11/08/2026

Detailed composition

Substance Quantity Type Category
SARS-CoV-2 XFG mRNA
50.0 UG Substance Wirkstoff (Principe actif)
heptadecan-9-ylis 8-((2-hydroxyethyl)(6-oxo-6-(undecyloxy)hexyl)amino)-octanoas
- Substance HNIDK
cholesterolum
- Substance HNIDK
1,2-distearoyl-sn-glycero-3-phosphocholinum
- Substance HNIDK
1,2-dimyristoyl-rac-glycero-3-polyethylenglycoli 2000 aether methylicus
- Substance HNIDK
trometamolum
- Substance HNIDK
trometamoli hydrochloridum
- Substance HNIDK
acidum aceticum
- Substance HNIDK
natrii acetas trihydricus
- Substance HNIDK
saccharum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
0.017 MG Substance HBESI

Reimbursement information

Public price
CHF 94.75
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2026

Authorization holder

Moderna Switzerland GmbH

4052 Basel

Authorization information

Swissmedic authorization number
70847
Drug name
Spikevax XFG
Galenic form
DISIJ
ATC Code
J07BN01
Authorization status
Z
Dispensing category
B
First authorization
10/08/2026
Authorization expiration date
09/08/2031
IT Number
08.08.
Domain
Human medicine
Field of application
Spikevax XFG ist für die aktive Immunisierung zur Vorbeugung der durch das SARS-CoV-2-Virus verursachten Coronavirus-2019-Erkrankung (COVID-19) bei Personen ab 12 Jahren indiziert.

Package details

Description (FR)
SPIKEVAX XFG (50 Microgramm) Injektionsdispersion
Description (DE)
SPIKEVAX XFG (50 Microgramm) Injektionsdispersion
Market launch
01/09/2026
Narcotic (BTM)
No

Other package sizes (1)

SPIKEVAX XFG (50 Microgramm) Injektionsdispersion
10 FESP
GTIN: 7680708470027
View
Buy us a coffee Explore the data